Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Ten reasons why DHBs need to act to control prescription pricing
+Columns
Ten reasons why DHBs need to act to control prescription pricing
Monday 12 February 2018, 10:17 AM

Anna Mickell
With Chemist Warehouse bursting onto the scene late last year offering zero prescription fees, prescription pricing has again become a topic of conversation. After working as a pharmacy wholesaler for 10 years, and in health in general for 35 years, pharmacy sector observer Anna Mickell has a few ideas on what works and what doesn’t. She gives her opinion on why prescription prices need to be controlled by DHBs
Despite a few left-leaning tendencies, I support a market approach when it comes to matters of health.
I think the Government and its agents need t, Anna Mickell 2018, Anna Mickell
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.